home.aspx
 
EVENTS

Symposium on Advanced Wound Care Fall
SYMPOSIUM ON ADVANCED WOUND CARE FALL
October 30-01, 2020
The Symposium on Advanced Wound Care Fall meeting (SAWC Fall) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes thro...

Vital Signs EMS Conference
VITAL SIGNS EMS CONFERENCE
October 29-01, 2020
Vital Signs EMS Conference will be showcasing many of the extraordinary aspects of EMS and healthcare found only in Saratoga Springs. This event provided high quality and cutting edge EMS education by providing access to national and world-renowned educators through a forum that is accessible and af...

CEVA SANTE ANIMALE

SHARESHARESHARE
Ceva Santé Animale is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for companion animals, livestock, swine and poultry.
SHARESHARESHARE

RELATED NEWS


A new report has found that there are more than 2,000 immunotherapy drugs now in development for cancer, with 940 of these in clinical stage development and 1,064 at the preclinical stage. The report, “Comprehensive Analysis of the Immuno-Oncology Landscape” by the Cancer Research Institute (CRI), is a first-of-its-kind independent analysis of the global immuno-oncology landscape, from agents in pre-clinical development to regulatory approval. The report says that the significant num...

READ MORE

Roche’s Tecentriq (atezolizumab) cancer immunotherapy has gained a new indication in the US after the FDA granted it a license in a difficult to treat the form of lung cancer in combination with chemotherapy. The regulator granted the new indication as a treatment for adults with extensive-stage small cell lung cancer (ES-SCLC) in combination with carboplatin and etoposide in previously untreated patients. Approval is based on results from the phase 3 Impower133 study, showing Tecentriq in...

READ MORE

AstraZeneca and Merck & Co’s Lynparza could offer a new option for certain patients with pancreatic cancer after a trial showed it slowed progression of the disease. Lynparza (olaparib) is a poly (ADP-ribose) polymerase, or PARP inhibitor class drug and is already established as a therapy for ovarian and breast cancer with BRCA mutations. The results add to the evidence that Lynparza and perhaps other PARP class drugs could work in other types of cancer that have the mutation, after ap...

READ MORE

SAN FRANCISCO, Dec. 06, 2016 (GLOBE NEWSWIRE) -- BioQ Pharma Incorporated, a specialty pharmaceutical company, today announced the signing of a strategic distribution, supply and development agreement to commercialize three infusion pharmaceuticals in the United Kingdom and the Republic of Ireland with Galen Limited, a specialty pharmaceutical company marketing products within the UK, Ireland, Europe and the US in therapeutic areas such as pain management, gastroenterology and female health....
GLOBENEWSWIRE.COM
READ MORE

With its once-biggest seller Velcade bracing for generic competition, Takeda has big plans for its oral multiple myeloma drug Ninlaro. But now, the med has suffered two setbacks in the span of a few months. After Ninlaro hit a snag at the FDA in an expanded use back in February, the company this week canned a phase 3 trial in another rare disease. Ninlaro had been in phase 3 testing for patients with systemic light-chain amyloidosis, but an analysis showed the med didn't meet a primary endpo...

READ MORE

AMRA Medical, a company based in Linköping, Sweden, won FDA clearance to introduce its AMRA Profiler technology for fat and muscle composition analysis. The product relies on a six-minute MRI scan, performed using a compatible scanner, with the imaging data being sent to AMRA’s servers. AMRA, in turn, delivers individualized reports that can be read by physicians and shared with patients. The AMRA Profiler is the first product able to convert a short MRI into a high-quality 3D fat and...

READ MORE

EVENTS

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...

Vital Signs EMS Conference
VITAL SIGNS EMS CONFERENCE
October 29-01, 2020
Vital Signs EMS Conference will be showcasing many of the extraordinary aspects of EMS and healthcare found only in Saratoga Springs. This event provided high quality and cutting edge EMS education by providing access to national and world-renowned educators through a forum that is accessible and af...